Login Register Cart 0
Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Yellow Fever Vaccination in Hemodialysis Patients: A Systematic Review

Author(s): Emery Ciana Figueiredo Vidal, Glaucia Luciano da Veiga, Marcelo Rodrigues Bacci*, Eglidia Carla Figueiredo Vidal, Beatriz da Costa Aguiar Alves, Thais Gascon and Fernando Luiz Affonso Fonseca

Volume 18, Issue 3, 2023

Published on: 10 February, 2023

Page: [205 - 210] Pages: 6

DOI: 10.2174/1574885518666230123160533

Price: $65

Abstract

Introduction: Yellow fever is an infectious disease endemic to Africa, and Central and South America with a significant impact on public health, causing outbreaks and epidemics. Clinical manifestations can vary from asymptomatic to more severe and lethal disease outcomes. The primary prevention of yellow fever occurs through the vaccination of individuals, which confers immunity for life. Patients with chronic kidney disease, especially those undergoing dialysis, have low vaccination and seroconversion rates. As mentioned above, this research aimed to perform a systematic review of the yellow fever vaccination protocol in hemodialysis patients.

Methods: A systematic review on vaccination against yellow fever in hemodialysis patients using databases, PubMed and Biblioteca Virtual em Saúde (BVS), was performed. For data collection, combinations were made using the following descriptors: protocols, vaccination, yellow fever, kidney dialysis, chronic kidney failure, chronic kidney disease, and group risk included in the title and abstract description. Articles with no subject related to the search were excluded and also if they were duplicated.

Results: In this review, 90 scientific articles were identified in both databases. After applying exclusion criteria, a total of 3 articles were selected.

Conclusion: We recommend carefully assessing the risk-benefit and contraindications for the patient, emphasizing the risk groups. There is an evident lack of studies on the subject, and there is a need to broaden investigations related toimmunization for patients on dialysis. The review is registered in the PROSPERO system with the number 323550.

« Previous Next »
Graphical Abstract

[1]
Oliveira WK. Health Surveillance Guide. 3rd ed. Brasilia: Brazilian Health Ministry. 2019. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_3ed.pdf
[2]
Ferreira KV, Rocha KC, Caputto LZ, Fonseca ALA, Fonseca FLA. Historical of yellow fever in Brazil and the importance of vaccination. Arquivos Brasileiros Ciências Saúde 2011; 36(1): 40-7.
[3]
Siqueira A, Costa BF, Carmo EH, et al. Yellow fever: a guide to healthcare professionals. 1st ed. Brasília: Brazilian Health Ministry. 2017. Available from:https://bvsms.saude.gov.br/bvs/publicacoes/febre_amarela_guia_profissionais_saude.p
[4]
Cavalcante KRLJ, Tauil PL. Risk of re-emergence of urban yellow fever in Brazil. Epidemiol Serv Saude 2017; 26(3): 617-20.
[http://dx.doi.org/10.5123/S1679-49742017000300018] [PMID: 28977185]
[5]
Thomas R. Yellow fever vaccine-associated viscerotropic disease: current perspectives. Drug Des Devel Ther 2016; 10(10): 3345-53.
[http://dx.doi.org/10.2147/DDDT.S99600] [PMID: 27784992]
[6]
de Oliveira Figueiredo P, Stoffella-Dutra AG, Barbosa Costa G, et al. Re-emergence of yellow fever in brazil during 2016–2019: challenges, lessons learned, and perspectives. Viruses 2020; 12(11): 1233.
[http://dx.doi.org/10.3390/v12111233] [PMID: 33143114]
[7]
Pileggi GS, Da Mota LMH, Kakehasi AM, et al. Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases. Adv Rheumatol 2019; 59(1): 17.
[http://dx.doi.org/10.1186/s42358-019-0056-x] [PMID: 31036077]
[8]
Manual of rules and procedures for vaccination. Brasilia: Brazilian Health Ministry. 2014. Available from: https://bvsms.saude. gov.br/bvs/publicacoes/manual_procedimentos_vacinacao.pdf
[9]
World Health Organization. Yellow fever. 2019. Available from https://www.who.int/news-room/fact-sheets/detail/yellow-fever
[10]
Thomas RE, Williamson T, Lorenzetti DL, Spragins W, Jackson D. The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review. Am J Trop Med Hyg 2012; 86(2): 359-72.
[http://dx.doi.org/10.4269/ajtmh.2012.11-0525] [PMID: 22302874]
[11]
Brazilian Immunization Society. Yellow fever technical note. SãoPaulo. 2017. Available from: https://sbim.org.br/images/files/nt-fa-sbim-170417.pdf
[12]
Tavares W, Marinho LA. Routines for diagnosing and treating infectious and parasitic diseases. 4th ed. São Paulo: Atheneu Ed 2015.
[13]
Department of Health Surveillance Department of Communicable Disease Surveillance. Technical Note No. 94 Guidelines and indication of a single dose of the yellow fever vaccine. Brasilia: Brazilian Health Ministry. 2017. Available from: http://www.vs. saude.ms.gov.br/wp-content/uploads/2018/01/NotaInformativa94-FA- DOSE-%C3%9ANICA.pdf
[14]
Ministry of Health. Health Care Department. Department of Specialized and Thematic Care. Clinical Guidelines for the care of patients with chronic kidney disease. Brasilia: Brazilian Health Ministry 2014. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/manual_procedimentos_vacinacao.pdf
[15]
Silva AS, Silveira RS, Fernandes GF, Lunardi VL, Backes VM. Perceptions and changes in the quality of life of patients submitted to hemodyalisis. Rev Bras Enferm 2011; 64(5): 839-44.
[http://dx.doi.org/10.1590/S0034-71672011000500006] [PMID: 22460483]
[16]
Neves PDMM, Sesso RCC, Thomé FS, Lugon JR, Nasicmento MM. Brazilian Dialysis Census: analysis of data from the 2009-2018 decade. J Bras Nefrol 2020; 42(2): 191-200.
[http://dx.doi.org/10.1590/2175-8239-jbn-2019-0234] [PMID: 32459279]
[17]
Souza MT, Silva MD, Carvalho R. Integrative review: what is it? How to do it? Einstein 2010; 8(1): 102-6.
[http://dx.doi.org/10.1590/s1679-45082010rw1134] [PMID: 26761761]
[18]
Porudominsky R, Gotuzzo EH. Yellow fever vaccine and risk of developing serious adverse events: a systematic review. Rev Panam Salud Publica 2018; 42: e75.
[http://dx.doi.org/10.26633/RPSP.2018.75] [PMID: 31093103]
[19]
Lopes RL, Pinto JR, Silva Junior GB, Santos AKT, Souza MTO, Daher EDF. Kidney involvement in yellow fever: a review. Rev Inst Med Trop São Paulo 2019; 61: e35.
[http://dx.doi.org/10.1590/s1678-9946201961035] [PMID: 31340247]
[20]
Facincani T, Guimarães MNC, De Sousa SS. Yellow fever vaccination status and safety in hemodialysis patients. Int J Infect Dis 2016; 48: 91-5.
[http://dx.doi.org/10.1016/j.ijid.2016.05.017] [PMID: 27208638]
[21]
Brazilian Society of Nephrology. Sao Paulo, SP: Yellow fever vaccination. Available from: https://www.sbn.org.br/profissional/sbn-cientifico/blog-cientifico/single-cientifica/news/vacinacao-febre-amarela/

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy